Inhibikase Therapeutics (IKT) Debt Ratio (2020 - 2025)

Inhibikase Therapeutics (IKT) reported Debt Ratio of 0.0 for Q2 2025, down 97.52% year-over-year from 0.02 in Q2 2024, and down 46.15% quarter-over-quarter from 0.0 in Q1 2025.

Inhibikase Therapeutics (IKT) Debt Ratio (2020 - 2025) Analysis & Trends

Inhibikase Therapeutics (IKT) has 6 years of Debt Ratio data on file, last reported at 0.0 in Q2 2025.

  • Debt Ratio for Q2 2025 came in at 0.0, down 97.52% year-over-year; the trailing twelve-month figure through Jun 2025 was 0.0 (down 97.52% YoY), and the FY2024 annual result was 0.0, down 89.17% from the prior year.
  • Debt Ratio fell to 0.0 in Q2 2025 per IKT's latest filing, from 0.0 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.03 in Q3 2024 and troughed at 0.0 in Q2 2025.
  • A 5-year average of 0.01 and a median of 0.01 in 2022 frame the typical range for Debt Ratio.
  • The sharpest annual moves came in 2024 and 2025: Debt Ratio soared 298.06% in 2024, then slumped 97.52% in 2025.
  • A 5-year view of Debt Ratio shows it stood at 0.01 in 2021, then advanced by 15.64% to 0.01 in 2022, then soared by 76.92% to 0.01 in 2023, then plunged by 89.17% to 0.0 in 2024, then slumped by 61.9% to 0.0 in 2025.
  • Business Quant data shows IKT's Debt Ratio at 0.0 in Q2 2025, 0.0 in Q1 2025, and 0.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 0.18
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -
9 Abivax 91.71 Bn 91.71 Bn - -
10 Inhibikase Therapeutics 285.17 Mn 114.80 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 0.03
Jun 30, 2024 0.02
Mar 31, 2024 0.01
Dec 31, 2023 0.01
Sep 30, 2023 0.01
Jun 30, 2023 0.01
Mar 31, 2023 0.01
Dec 31, 2022 0.01
Sep 30, 2022 0.00
Jun 30, 2021 0.01
Mar 31, 2021 0.02
Dec 31, 2020 0.02